Celebrating 10 years of innovative, global,
Regulatory solutions & services for Life Sciences industry

Supplying Medicines to Northern Ireland from 1 January 2021

Goods placed on the market in the European Union or the United Kingdom before the end of the transition period may continue to circulate between these two markets from 1 January 2021. This includes medicines moving from Great Britain to Northern Ireland. Medicines placed on the market before 11pm on 31 December 2020 qualify for continued circulation.

Medicines placed on the market before 11pm on 31 December 2020 may be supplied to a wholesaler or other authorised person in Northern Ireland- Checks should be performed to confirm that a medicine has met the 'placed on the market' criteria. Manufacturers are encouraged to ensure that the date of placing on the market is visible to the supply chain.

Source: MHRA guideline on Supplying medicines to Northern Ireland from 1 January 2021

Latest Resources

  • Blogs

    Brexit: The MHRA and The Proposed eSubmission Portal

    Read More
  • White Papers

    Impact of COIVD – 19 on FMCG Supply Chain Regulatory Compliance

    Read More
  • Case Studies

    Expedited Product Classification and NIOSH Certification for N95 Respirator

    Read More

What our Clients Say?

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Quick Inquiry
x